Divi's Laboratories has reported results for second quarter ended September 30, 2022.
The company has reported a fall of 19.71% in its net profit at Rs 486.85 crore for the quarter under review as compared to Rs 606.39 crore for the same quarter in the previous year. Total income of the company decreased by 4.24% at Rs 1902.63 crore for Q2FY23 as compared Rs 1986.97 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 18.61% in its net profit at Rs 493.60 crore for the quarter under review as compared to Rs 606.46 crore for the same quarter in the previous year. Total income of the company marginally fall by 3.59% at Rs 1934.62 crore for Q2FY23 as compared Rs 2006.62 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1502.30 |
Dr. Reddys Lab | 6198.90 |
Cipla | 1402.20 |
Zydus Lifesciences | 957.00 |
Lupin | 1645.00 |
View more.. |